SCIENTIFIC BACKGROUND

DES, DSC2, DSG2, DSP, JUP, LMNA, PKP2, PLN, TGFB3, TMEM43

Arrythmogenic right ventricular cardiomyopathy (ARVC) is a mostly autosomal dominant inherited disease of the heart muscle in which the myocardium is progressively replaced by fatty and connective tissue. The connective tissue remodeling, which mainly affects the right ventricle, initially leads to a disturbance of the stimulus conduction with ventricular arrythmias, palpitations or syncope. The ECG typically shows epsilon waves and an inverted T-wave with broadened QRS complex in right precordial recording.

 

The arrythmias that can lead to sudden cardiac death are usually triggered by physical exertion. About one third of the index patients die suddenly between the ages of 14-20 years and this age seems to be a vulnerable period for fatal arrythmias. However, half of the carriers do not develop clinical symptoms until over 50 years of age and about one third do not become ill until old age. The frequency of ARVC is estimated at 1:5,000, and about half of the cases show a familial clustering. More than ten different forms of ARVC have now been documented.

 

The most common forms are caused by variants in genes that code for components of the desmosomes (cell-cell connections). Molecular genetic analysis of the genes that encode desmoplakine (DSP), plakophilin-2 (PKP2) and desmoglein-2 (DSG2) reveals variants in about 50-60% of patients. In about 5% of cases, the hereditary form of ARVC is caused by variants of other desmosomal protein genes such as plakoglobin (JUP) and desmocollin-2 (DSC2), as well as other genes such as transmembrane protein 43 (TMEM43) and transforming growth factor beta-3 (TGFB3). To date, no genetic cause can be proven in about 40% of ARVC cases.

 

References

Hall et al. 2018, Eur J Hum Genet doi.org/10.1038/s41431-018-0169- 4 / Walsh et al. 2017, Genet Med 19:192 / Medeiros-Domingo et al. 2016, Europace pii: euw098 / Bhonsale et al. 2015, Eur Heart J epub Jan / Schulze-Bahr et al. 2015, Kardiologe DOI 10.1007/s12181-014-0636-2 / Campuzano et al. 2013, J Med Genet 50:280 / Quarta et al. 2011, Circulation 123:2701 / Ackerman et al. 2011, Europace 13:1077

GENES

DES, DSC2, DSG2, DSP, JUP, LMNA, PKP2, PLN, TGFB3, TMEM43
How to order

LATEST ARTICLES

Neurodevelopmental disorders (NDDs) have diverse genetic origins, making diagnosis challenging. A new study analyzing over 1,100 pediatric patients f...

Read more

Colorectal cancer (CRC) remains one of the most prevalent and deadly cancers worldwide, with a significant number of cases presenting at an advanced ...

Read more

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant...

Read more